Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1970 Dec;40(4):759–774. doi: 10.1111/j.1476-5381.1970.tb10653.x

Investigations into the mechanism of the antifertility action of minimal doses of megestrol acetate in the rabbit

K E Kendle, J M Telford
PMCID: PMC1702907  PMID: 4992956

Abstract

1. Experiments have been performed to investigate the mechanism by which low doses of megestrol acetate have an antifertility action.

2. It was found that the dose of megestrol acetate required to prevent pregnancy in nine of ten New Zealand White rabbits when given on 3 consecutive days, the last of which was the day of insemination, was 50 μg/kg daily.

3. This treatment reduced the numbers of sperm recoverable from the uterus at various times after insemination, but egg transfer experiments showed that neither egg viability nor fertilization was affected on day 1 of pregnancy.

4. Treatment with megestrol acetate for 3 days caused the fertilized eggs to enter the uterus approximately 48 h prematurely. Treatment with megestrol acetate for longer periods caused a similar but more marked increase in the rate of transport of eggs in the oviduct.

5. Megestrol acetate did not modify oviduct opening pressure, but the volume of oviduct fluid secretion was reduced earlier and transport of fluid through the oviduct was accelerated compared with controls.

6. Transfer of eggs on various days from the uteri of untreated rabbits to the uteri of treated rabbits indicated that the development of the endometrium which occurs in pregnancy may be advanced by megestrol administration. Histological examination of the endometrial proliferation induced by megestrol acetate confirmed that this was so.

7. It is concluded that the antifertility action of megestrol acetate in doses that do not necessarily inhibit ovulation is due to a combination of accelerated egg transport and advanced endometrial development.

Full text

PDF
759

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chang M. C. Effects of oral administration of medroxyprogesterone acetate and ethinyl estradiol on the transportation and development of rabbit eggs. Endocrinology. 1966 Nov;79(5):939–948. doi: 10.1210/endo-79-5-939. [DOI] [PubMed] [Google Scholar]
  2. Chang M. C. Effects of progesterone and related compounds on fertilization, transportation and development of rabbit eggs. Endocrinology. 1967 Dec;81(6):1251–1260. doi: 10.1210/endo-81-6-1251. [DOI] [PubMed] [Google Scholar]
  3. Cox H. J. Progestogen-only oral contraceptives. Br Med J. 1969 Aug 23;3(5668):471–472. doi: 10.1136/bmj.3.5668.471-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Foss G. L., Svendsen E. K., Fotherby K., Richards D. J. Contraceptive action of continuous low doses of norgestrel. Br Med J. 1968 Nov 23;4(5629):489–491. doi: 10.1136/bmj.4.5629.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gibor Y., Cohen M. R., Scommegna A. Effect of continuous administration of small doses of chlormadinone acetate on the cervical mucus and postcoital test. Fertil Steril. 1969 Jul-Aug;20(4):572–580. doi: 10.1016/s0015-0282(16)37083-2. [DOI] [PubMed] [Google Scholar]
  6. HILLIARD J., ARCHIBALD D., SAWYER C. H. Gonadotropic activation of prevulatory synthesis and release of progestin in the rabbit. Endocrinology. 1963 Jan;72:59–66. doi: 10.1210/endo-72-1-59. [DOI] [PubMed] [Google Scholar]
  7. Howard G., Blair M., Elstein M., Morris N. F. Low-dose continuous chlormadinone acetate as an oral contraceptive. A clinical trial. Lancet. 1969 Jul 5;2(7610):24–26. doi: 10.1016/s0140-6736(69)92599-9. [DOI] [PubMed] [Google Scholar]
  8. Macdonald R. R., Lumley I. B., Coulson A., Stitch S. R. Chlormadinone acetate as an oral contraceptive: clinical results and the incidence of ovulation. J Obstet Gynaecol Br Commonw. 1968 Nov;75(11):1123–1127. doi: 10.1111/j.1471-0528.1968.tb02895.x. [DOI] [PubMed] [Google Scholar]
  9. Martinez-Manautou J., Cortez V., Giner J., Aznar R., Casasola J., Rudel H. W. Low doses of progestogen as an approach to fertility control. Fertil Steril. 1966 Jan-Feb;17(1):49–57. doi: 10.1016/s0015-0282(16)35825-3. [DOI] [PubMed] [Google Scholar]
  10. Martinez-Manautou J., Giner-Velasquez J., Cortes-Gallegos V., Aznar R., Rojas B., Guitterez-Najar A., Rudel H. W. Daily progestogen for contraception: a clinical study. Br Med J. 1967 Jun 17;2(5554):730–732. doi: 10.1136/bmj.2.5554.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Martinez-Manautou J., Giner-Velasquez J., Rudel H. Continuous progestogen contraception: a dose relationship study with chlormadinone acetate. Fertil Steril. 1967 Jan-Feb;18(1):57–61. doi: 10.1016/s0015-0282(16)36185-4. [DOI] [PubMed] [Google Scholar]
  12. McPhail M. K. The assay of progestin. J Physiol. 1934 Dec 31;83(2):145–156. doi: 10.1113/jphysiol.1934.sp003217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mears E., Vessey M. P., Andolsek L., Oven A. Preliminary evaluation of four oral contraceptives containing only progestogens. Br Med J. 1969 Jun 21;2(5659):730–734. doi: 10.1136/bmj.2.5659.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. RUDEL H. W., MARTINEZ MANAUTOU J., MAQUEO TOPETE M. THE ROLE OF PROGESTOGENS IN THE HORMONAL CONTROL OF FERTILITY. Fertil Steril. 1965 Mar-Apr;16:158–169. doi: 10.1016/s0015-0282(16)35522-4. [DOI] [PubMed] [Google Scholar]
  15. Vickery B. H., Bennett J. P. Mechanisms of antifertility action of chlormadinone acetate in the rabbit. Biol Reprod. 1969 Dec;1(4):372–377. doi: 10.1093/biolreprod/1.4.372. [DOI] [PubMed] [Google Scholar]
  16. Zañartu J., Pupkin M., Rosenberg D., Guerrero R., Rodriguez-Bravo R., Garcia-Huidobro M., Puga J. A. Effect of oral continuous progestogen therapy in microdosage on human ovary and sperm transport. Br Med J. 1968 May 4;2(5600):266–269. doi: 10.1136/bmj.2.5600.266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Zañartu J., Rodriguez-Moore G., Pupkin M., Salas O., Guerrero R. Antifertility effect of continuous low-dosage oral progestogen therapy. Br Med J. 1968 May 4;2(5600):263–266. doi: 10.1136/bmj.2.5600.263. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES